No takes yet. Share an insight, caveat, or question.
Highlights the need for frequent dose modifications and alternate dosing regimens when using recombinant human antithrombin concentrate in pregnant women with antithrombin deficiency.
Kreuziger et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: